SCIENION GmbH

Their core work

SCIENION GmbH is a Berlin-based technology SME specializing in the fabrication and manufacturing of micro- and nanoscale devices, with particular depth in roll-to-roll (R2R) imprinting and nano-enabled surface engineering. Their practical contribution to EU projects centers on making microfluidic devices manufacturable at scale — bridging the gap between laboratory prototypes and industrially viable products. In both funded projects they brought hands-on fabrication expertise: first for bioanalytical devices produced via large-scale R2R imprinting, and more recently for validating upscaling pathways for microfluidic devices built on nano-enabled surfaces and membranes. Their work sits at the intersection of advanced materials processing and device manufacturing readiness.

What they specialise in

How they've shifted over time

In their first funded project (2015–2019), SCIENION's contribution was primarily a fabrication one: applying R2R imprinting to manufacture bioanalytical devices at large scale, with no recorded focus on regulatory or commercialization concerns. By their second project (2020–2025), the scope had broadened noticeably — the keyword set now includes quality management, time to market, and regulation alongside the core nano-fabrication topics, suggesting the organization moved from pure process capability toward manufacturing readiness and technology transfer. This shift points to a maturing company that has moved past proving the technology works and is now focused on proving it can be produced reliably and sold.

SCIENION appears to be positioning itself as a bridge between nano-fabrication research and industrial-scale production, increasingly bringing quality, regulatory, and market-readiness expertise to consortia alongside its core manufacturing capabilities.

How they like to work

SCIENION has participated exclusively as a consortium member — never as coordinator — across both funded projects, suggesting they prefer to contribute focused technical expertise rather than manage projects. Their network of 25 unique partners across 9 countries from just two projects indicates they operate within broad, pan-European consortia rather than tight bilateral arrangements. This profile is typical of a specialist manufacturer that consortia seek out for a specific capability gap — in this case, scalable nano- and microfabrication — rather than for leadership or administrative roles.

SCIENION has built a surprisingly wide network for a small company with only two projects — 25 distinct partners spread across 9 countries, suggesting active participation in large multi-partner Innovation Actions. Their geographic spread across Europe points to engagement with major R&D hubs beyond Germany.

What sets them apart

SCIENION occupies a specific niche that is hard to fill in consortia: a private SME with hands-on roll-to-roll nanofabrication capability and the industrial mindset to think about upscaling, quality management, and time to market from the start. Unlike university research groups that can model or characterize nano-surfaces, SCIENION can actually manufacture them at scale and validate the process under near-industrial conditions. For any consortium trying to push a microfluidic or nano-surface technology toward TRL 6–8, they bring the manufacturing credibility that academic partners cannot.

Highlights from their portfolio

• NextGenMicrofluidics
  Their largest and most recent project (€288,750, running to 2025) is the most revealing — it combines nano-enabled materials with an explicit upscaling and commercialization mandate, covering quality management and regulatory aspects that signal industrial-grade ambitions.
• R2R Biofluidics
  Their entry into EU-funded research (2015–2019) established their roll-to-roll imprinting credentials in the bioanalytical device space, providing the technical foundation that later projects build upon.